Rx (Prescription Medicine)
USD $ 30.00
USD $ 1.00 per tablet
Bdpazo 400mg Tablet 是一种含有活性成分帕扎帕尼的药物。帕扎帕尼属于一种靶向治疗药物，称为酪氨酸激酶抑制剂。它通过阻断参与癌细胞生长和转移的特定蛋白来发挥作用。通过抑制这些蛋白，Bdpazo 有助于减缓或停止肿瘤的生长，并还能阻止为癌症提供血液供应的新血管的形成。
Bdpazo 400mg Tablet 主要用于治疗晚期肾细胞癌（肾癌）和晚期软组织肉瘤，适用于已接受化疗的成人患者。常规剂量为 800mg，每日两次，空腹服用。务必遵循医生关于剂量和治疗时长的指示。常见的不良反应可能包括腹泻、高血压、头发颜色改变、恶心和疲劳。虽然罕见但可能出现严重的不良反应，因此请立即向您的医疗提供者报告任何异常症状。请将 Bdpazo 400mg Tablets 存放于室温，避免潮湿和热源。
其他品牌的 Pazopanib 400 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
